English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

Integrating knowledge from a variety of published reports is a crucial aspect in the development of bioactive entities. Unfortunately, the analysis of the enormous body of items of information reported in the literature for biologically active compounds is hampered by the lack of both uniformity and completeness of data.

Shouldn't enantiomeric purity be included in the 'minimum information about a bioactive entity'?